Heather A. Hirsch

644 total citations
19 papers, 420 citations indexed

About

Heather A. Hirsch is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Heather A. Hirsch has authored 19 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Heather A. Hirsch's work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (4 papers). Heather A. Hirsch is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (4 papers). Heather A. Hirsch collaborates with scholars based in United States, United Kingdom and Russia. Heather A. Hirsch's co-authors include R. William Henry, Liping Gu, Brian J. Long, Leigh Zawel, Stephen E. Fawell, Amy D. Guertin, Igor Feldman, Carlo Toniatti, Stuart D. Shumway and Alwin G. Schuller and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Heather A. Hirsch

16 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heather A. Hirsch United States	9	235	234	76	69	39	19	420
Perrine Garde‐Granger Canada	11	166 0.7×	125 0.5×	117 1.5×	36 0.5×	52 1.3×	12	349
Antonia Wenners Germany	11	102 0.4×	101 0.4×	51 0.7×	35 0.5×	74 1.9×	21	306
Margaret C. Sunderland United States	9	272 1.2×	119 0.5×	136 1.8×	34 0.5×	76 1.9×	11	420
Jie‐Hua He China	10	214 0.9×	199 0.9×	16 0.2×	83 1.2×	47 1.2×	11	390
Xiangyan Jiang China	12	159 0.7×	203 0.9×	74 1.0×	85 1.2×	83 2.1×	26	409
Neelakantan Vijayalakshmi India	6	94 0.4×	233 1.0×	55 0.7×	40 0.6×	102 2.6×	6	351
Jodi A. McKenzie United States	8	121 0.5×	155 0.7×	81 1.1×	73 1.1×	54 1.4×	30	302
Keshuai Dong China	14	131 0.6×	193 0.8×	34 0.4×	54 0.8×	133 3.4×	26	418
Kenji Kido Japan	9	272 1.2×	213 0.9×	125 1.6×	99 1.4×	59 1.5×	17	469
Inês M. Gomes Portugal	9	132 0.6×	158 0.7×	81 1.1×	140 2.0×	50 1.3×	10	373

Countries citing papers authored by Heather A. Hirsch

Since Specialization

Citations

This map shows the geographic impact of Heather A. Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather A. Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather A. Hirsch more than expected).

Fields of papers citing papers by Heather A. Hirsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather A. Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather A. Hirsch. The network helps show where Heather A. Hirsch may publish in the future.

Co-authorship network of co-authors of Heather A. Hirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Heather A. Hirsch. A scholar is included among the top collaborators of Heather A. Hirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather A. Hirsch. Heather A. Hirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dorigo, Oliver, Amit M. Oza, Tanja Pejović, et al.. (2023). Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial. Clinical Cancer Research. 29(15). 2808–2815. 7 indexed citations

Hirsch, Heather A., et al.. (2021). An Evaluation of Achieving Condom Empowerment (ACE)-Plus in Foster Care Agencies in New York City. American Journal of Sexuality Education. 17(1). 1–18.

Yap, Timothy A., Howard A. Burris, Shivaani Kummar, et al.. (2018). ICONIC: Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011 +/- nivolumab (nivo) in patients (pts) with advanced cancers.. Journal of Clinical Oncology. 36(15_suppl). 3000–3000. 28 indexed citations

Bregar, Amy, Amit Deshpande, Tong Zi, et al.. (2017). Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors. Gynecologic Oncology. 145(3). 446–452. 50 indexed citations

Michaelson, Jennifer S., Christopher J. Harvey, Kutlu G. Elpek, et al.. (2017). Abstract SY03-02: Preclinical assessment of JTX-2011, an agonist antibody targeting ICOS, supports evaluation in ICONIC clinical trial. Cancer Research. 77(13_Supplement). SY03–2. 2 indexed citations

Wagner, Andrew J., Udai Banerji, Amit Mahipal, et al.. (2017). Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 35(12). 1304–1311. 95 indexed citations

Haines, Brian B., Sarah Javaid, Long Cui, et al.. (2017). Abstract 4714: Blockade of LAG-3 amplifies immune activation signatures and augments curative antitumor responses to anti-PD-1 therapy in immune competent mouse models of cancer. Cancer Research. 77(13_Supplement). 4714–4714. 6 indexed citations

Pinheiro, Elaine M., Ruban Mangadu, Mingmei Cai, et al.. (2016). Abstract 543: Preclinical combination strategies to enhance the efficacy of the anti-PD-1 antibody pembrolizumab. Cancer Research. 76(14_Supplement). 543–543.

Wagner, Andrew J., Udai Banerji, Amit Mahipal, et al.. (2015). A phase I trial of the human double minute 2 (HDM2) inhibitor MK-8242 in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 33(15_suppl). 10564–10564. 8 indexed citations

10.

Pinheiro, Elaine M., Ruban Mangadu, Uyen Phan, et al.. (2015). Abstract 269: Evaluation of the antitumor activity of anti-PD-1 immunotherapy as a single agent and in combination with approved agents in preclinical tumor models. Cancer Research. 75(15_Supplement). 269–269. 1 indexed citations

11.

Nebozhyn, Michael, Heather A. Hirsch, Răzvan Cristescu, et al.. (2015). Abstract 1307: Assessment of gene expression in peripheral blood from patients with advanced melanoma using RNA-seq before and after treatment with anti-PD-1 therapy with pembrolizumab (MK-3475). Cancer Research. 75(15_Supplement). 1307–1307. 1 indexed citations

12.

Hirsch, Heather A., Elaine M. Pinheiro, Mingmei Cai, et al.. (2015). Abstract 1328: Molecular characterization of mouse syngeneic tumor models in response to treatment with anti-PD-1 immunotherapy. Cancer Research. 75(15_Supplement). 1328–1328. 1 indexed citations

13.

Čemerski, Sašo, Shuxia Zhao, Mélissa Chénard, et al.. (2015). T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity. Journal for ImmunoTherapy of Cancer. 3(S2). 6 indexed citations

14.

Guertin, Amy D., Jing Li, Yaping Liu, et al.. (2013). Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy. Molecular Cancer Therapeutics. 12(8). 1442–1452. 143 indexed citations

15.

Booher, Robert, Heather A. Hirsch, Peter R. Strack, Leigh Zawel, & Stephen E. Fawell. (2012). Abstract 3063: Mcl-1 dependency is a predictive biomarker for apoptotic induction by short-term dinaciclib (SCH 727965) treatment. Cancer Research. 72(8_Supplement). 3063–3063. 4 indexed citations

16.

Hinkley, Craig S., Heather A. Hirsch, Liping Gu, Brandon LaMere, & R. William Henry. (2003). The Small Nuclear RNA-activating Protein 190 Myb DNA Binding Domain Stimulates TATA Box-binding Protein-TATA Box Recognition. Journal of Biological Chemistry. 278(20). 18649–18657. 22 indexed citations

17.

Hirsch, Heather A., Liping Gu, & R. William Henry. (2000). The Retinoblastoma Tumor Suppressor Protein Targets Distinct General Transcription Factors To Regulate RNA Polymerase III Gene Expression. Molecular and Cellular Biology. 20(24). 9182–9191. 25 indexed citations

18.

Boon, Thierry, B. Van den Eynde, Heather A. Hirsch, et al.. (1994). Genes Coding for Tumor-specific Rejection Antigens. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 617–622. 12 indexed citations

19.

König, Markus, et al.. (1992). Handschuhperforationen bei gynäkologischen Operationen und abdominalen Schnittentbindungen. Geburtshilfe und Frauenheilkunde. 52(2). 109–112. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact